Targeting IRAK4 in Chronic Lymphocytic Leukemia
ConditionChronic Lymphocytic Leukemia (CLL)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS San Raffaele
About this trial
Patients with chronic lymphocytic leukemia (CLL) followed at Strategic Research Program on CLL will be enrolled and undergo sampling of additional amount of blood at the time of standard blood tests. Leukemic B cells and peripheral blood mononuclear cells (PBMC).
Eligibility criteria
Qualifiers
Age ≥18 years
Diagnosis of CLL
Participant is willing and able to give informed consent for participation in the study.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Peripheral blood sample collection
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov